Roche Covid-19 and Influenza A/B Test Receives EUA
The test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B.
Read MorePosted by Laurie Bonner | Sep 4, 2020 | Covid 19, Hematology & Serology |
The test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B.
Read MorePosted by Melanie Hamilton-Basich | Sep 4, 2020 | Covid 19, Hematology & Serology |
The panel consists of 14 units of a unique human plasma sample drawn from a single donor during a developing SARS-CoV-2 infection.
Read MorePosted by Melanie Hamilton-Basich | Sep 4, 2020 | Covid 19, Hematology & Serology |
ImmunoRank is designed to test up to 90 samples per test kit with 99.8% specificity for the detection of SARS-CoV-2 neutralizing antibodies in plasma.
Read MorePosted by Laurie Bonner | Sep 2, 2020 | Hematology & Serology |
DNA origami—a nanoscale technique that involves folding DNA into specific shapes—can compile a detectable signal from just a few biomarkers.
Read MorePosted by Melanie Hamilton-Basich | Sep 1, 2020 | Company News, Covid 19, Hematology & Serology |
The rapid-results test requires only a fingerstick and delivers results in 15 minutes.
Read More